Lazada Seller & Partner Awards 2025 demonstrates Lazada's strengthened commitment to accelerating Indonesia's digital economy ahead of its year-end shopping festival series in 2025.
JAKARTA,...
Donor generosity provides lasting support for physician leadership, innovation and patient care in Orange County
ORANGE, Calif., Aug. 13, 2025 /PRNewswire/ -- Today Providence St....
Founder-built, female-founded company has over 50% revenue growth and multi-channel expansion
NEW YORK, Aug. 13, 2025 /PRNewswire/ -- Tiny Tags, the celebrity-loved personalized jewelry brand,...
RICHMOND, Va., Aug. 13, 2025 /PRNewswire/ -- In honor of Military Appreciation Month this past May, Potomac Family Dining, a proud Applebee's franchise group,...
HOWARD, Pa., Aug. 12, 2025 /PRNewswire/ -- Starway Roofing proudly hosted its first Annual Back-to-School Backpack Giveaway, providing 22 local children in kindergarten through...
Stephen Hahn to Transition to CEO Emeritus and Special Advisor and remain on Harbinger's board
CAMBRIDGE, Mass., Aug. 11, 2025 /PRNewswire/ -- Flagship Pioneering, the...
MONTREAL, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Boralex Inc. (“Boralex” or the “Company”) (TSX: BLX) announces the appointment of Mr. André Courville as Chair of the Board of Directors. He will officially succeed Mr. Alain Rhéaume on September 30, following Mr. Rhéaume’s retirement announced last June after 15 years of service on the Board, including eight as Chair.
MONTRÉAL, 08 août 2025 (GLOBE NEWSWIRE) -- Boralex inc. (« Boralex » ou la « Société ») (TSX : BLX) annonce la nomination de M. André Courville à titre de Président du Conseil d’administration. Il succèdera ainsi le 30 septembre prochain à M. Alain Rhéaume, qui a annoncé sa retraite en juin dernier après 15 ans de contribution au Conseil, dont huit à titre de Président.
HOUSTON, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) (“Crown Castle” or the “Company”) today announced that its Board of Directors has appointed Christian Hillabrant as President and Chief Executive Officer, effective September 15, 2025. Mr. Hillabrant is also expected to join the Company’s Board at that time.
BEIJING, Aug. 3, 2025 /PRNewswire/ -- Raytone Biotech, a clinical-stage biotechnology company dedicated to innovative ophthalmic therapies, announced that it successfully completed the first patient...